Latest KFF Health News Content

Latest KFF Health News Stories

Misterioso remedio: vacunas ayudan a enfermos de covid de largo plazo

KFF Health News Original

Es posible que las vacunas eliminen restos del virus o sus fragmentos, que interrumpan una respuesta autoinmune perjudicial o que, de alguna otra manera, “restablezcan” el sistema inmunitario.

Drug Company Sues Medical Journal

Morning Briefing

Pacira Biosciences sued Anesthesiology, claiming the medical journal disparaged its Exparel painkiller. Wall Street analysts think sales for the drug will nevertheless grow 50% this year. And cheating is alleged at Dartmouth’s medical school, but it could be that the school doesn’t understand computer technology.

States Push Against Mask Mandates For Schools And Sports

Morning Briefing

Education officials in Florida and Minnesota want to reduce mask use. In other news, anti-transgender laws are widely opposed in a new poll, and a call is made for more urgent care for women.

Physician Assistants Given Broader Scope In Florida Bill

Morning Briefing

In other news, Florida and Missouri make legal moves to adjust Medicaid provision, a long-delayed report on Medicaid in Georgia is released, and West Virginia’s governor signs a harm-reduction bill he’d been urged to veto by health professionals.

Biden Moves To Overturn More Trump Policies

Morning Briefing

Most recently, the Biden administration has moved against an exemption of a wide swath of medical devices and artificial intelligence tools from regulatory review and federal research that uses fetal tissue.

Another Covid Surge Appears Likely

Morning Briefing

At least 21 states have recorded at least a 10% rise in daily average positive covid cases. Overall, the U.S. has over 70,000 new covid cases a day. Hospitals are again getting stressed. (And two tigers in captivity in Virginia have tested positive.)

Merck’s Anti-Viral Covid Pill Works, But Only In Early Stages

Morning Briefing

As Merck reports results for its anti-covid pill that are promising, if only in the early stages of infection, other researchers say the P1 variant from Brazil is more transmissible than others. Worries emerge about next-gen covid vaccines. And one study shows dogs can sniff out covid-positive urine.

A Booster, Then Yearly Shots: Likely Future Vaccinations Mapped

Morning Briefing

Pfizer’s CEO says that people who received his company’s covid vaccine will probably need a third shot within 12 months of the original two-dose regimen. And Moderna targets the fall to have its expected booster shot available.

J&J Vaccine Gets More Negative Attention

Morning Briefing

Despite a study out of Oxford University showing the risk of blood clots is much higher with covid than with a vaccine against covid, the Johnson & Johnson vaccine continues to generate suspicion.